This Week in Psychedelics - 1.7.22

Cannabis

• Sadiq Khan plans pilot to ‘decriminalise’ minor cannabis offences in London (The Guardian)

• Legal recreational marijuana sales begin in Montana (KPAX)

• Federal Marijuana Monopoly Finally Ends As Two Companies Harvest Cannabis Approved By DEA (Marijuana Moment)

• New year rings in key changes to state marijuana markets (Marijuana Business Daily)

• GOP-Controlled New Hampshire House Votes To Legalize Marijuana Possession And Cultivation (Marijuana Moment)

• Colorado: Governor Issues Pardons to Over 1,300 Marijuana Offenders (NORML)

• Wyoming Marijuana Activists Turn Focus To 2024 Ballot For Decriminalization And Medical Cannabis Initiatives (Marijuana Moment)

• The top cannabis research studies of 2021 (Leafly)

• Incoming Virginia GOP Governor Won’t ‘Overturn’ Legal Marijuana Possession, But Casts Doubt On Sales (Marijuana Moment)

• Top Kansas Democrats Unveil Plan To Put Medical And Adult-Use Marijuana Legalization On The 2022 Ballot (Marijuana Moment)

• Two recreational marijuana initiatives might appear on Oklahoma ballot in fall (Marijuana Business Daily)

• Iowa Democrats Unveil Marijuana Resolution To Put Legalization On Ballot For Voters To Decide (Marijuana Moment)

• New Republican-Led Bill Would Legalize Medical Cannabis In Kentucky (Marijuana Moment)

• South Dakota Lawmakers Prepare Dozens Of Cannabis Reform Bills (High Times)

• Marijuana Decriminalization Reduces Arrests And Racial Disparities In Law Enforcement, Study Finds (Marijuana Moment)

• Tiny but mighty: Micro-cultivators dominated 2021 (Leafly)

• The cost of medical marijuana in Louisiana (KSLA)

• Israeli startup a go-to resource in medical cannabis world (I24News)

• Oklahoma Pot Farm Slapped with RICO From Next Door Neighbor (High Times)

• Cannabis users report higher quality of life than non-users (Leafie)

Magic Mushrooms

• Washington Psilocybin Bill Would Legalize Supported Adult Use (Bill of Health)

• COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology (Psilocybin Alpha)

• New Hampshire Bipartisan Bills Want to Reduce Penalties on Psilocybin, Other Drugs (Truffle Report)

• Tryp Therapeutics Announces Advancement of Phase 2a Clinical Trial in Binge Eating Disorder (Psilocybin Alpha)

• Filament Health Announces Health Canada Approval for Phase II Trial Administering New Psilocybin Microdose Formulation (Psilocybin Alpha)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete Second Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Psilocybin therapy options could expand in Hawaiʻi (Hawai'i Public Radio)

MDMA

• Drug testing: Dramatic drop in bath salts being sold as MDMA (Radio New Zealand)

• Microdosing MDMA: What Research Says About Doing It For Mental Health Issues (Healing Maps)

DMT

• Entheon Biomedical Provides Update on DMT Human Trial and Announces Regulatory Submission to Ethics Committee (Psilocybin Alpha)

Ayahuasca

• IRS defends denial of Des Moines church's tax-free status over use of psychedelic drug (KCCI)

• Anti-Drug GOP Senator Helps Psychedelic Church With Fight Against DEA And IRS (Marijuana Moment)

Iboga

• National Institute on Drug Abuse to Test Ibogaine For Addiction Treatment (Truffle Report)

• Caribbean Facility Finds Consistent Success Using Ibogaine for Anxiety and Trauma Treatment (PR Newswire)

Novel Psychoactive Substances

• MindMed Successfully Completes Phase 1 Clinical Trial of 18-MC (Psilocybin Alpha)

• Mindset Pharma Teams Up with The McQuade Center to Develop 2 Families of Novel Psychedelic Compounds (Psychedelic Spotlight)

Synthetic Cannabinoids

• Using cannabinoids to treat obesity (Medical Xpress)

• More needs to be done to tackle synthetic cannabinoids, experts say (Stuff.co.nz)

Ketamine

• Awakn Life Sciences Expands World's First Ketamine Study Beyond Gambling Disorder to Include Additional Behavioral Addictions (Yahoo!)

• PharmaTher Announces Publication of Research Data for KETABET™ (Psilocybin Alpha)

Miscellaneous

• The Promises and Perils of Psychedelic Health Care (The New York Times)

• Health Canada Grants Special Access to Restricted Drugs for Psychedelic Therapy (Psychedelic Spotlight)

• Magic mushroom companies are on the Nasdaq now. That’s a recipe for a bad trip (The Guardian)

• Psychedelics Can Change Your View on the Nature of Reality (Psychedelic Spotlight)

• Psychedelics in 2022: What to Expect (Truffle Report)

• Fact Check-London Mayor not decriminalising drugs (Reuters)

• Psychedelics 2021: A Year in Review (Psilocybin Alpha)

• Will overdose deaths force an end to the US ‘war on drugs’? (Financial Times)

• Philippines' Duterte says will never apologise for drug war deaths (Reuters)

• New York Prisons Punished 1,600 People for False Drug Test Results (Filter)

• Now psychedelics are coming to your medicine cabinet (ISRAEL21c)

• How Psychedelic Therapy Fuses Indigenous Shamanism With Western Science (IFLScience)

• Pop Culture Boosts Acceptance of Plant Medicine (GlobeNewswire)

• Can A Psychedelic Experience Improve 2022? (Reality Sandwich)

• Psychedelic Drug Policy Reform in 2021: A Year in Review (Psilocybin Alpha)

• Psychedelics Will Have a Big Presence at SXSW in 2022 (Psychedelic Spotlight)

• Was 2021 the Year Psychedelics Conquered Capitalism? (Green Entrepreneur)

• Startup To Host Psychedelic Trips In The Metaverse (Forbes)

• Is ‘The Trip’ Essential to The Psychedelic Experience? (Psychedelic Spotlight)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 10.1.21

Cannabis

• Bill To Federally Legalize Marijuana Approved By Key House Committee (Marijuana Moment)

• Marijuana Arrests Fall Precipitously Nationwide in 2020 (NORML)

• California Governor Signs Bill To Allow Medical Marijuana Use In Hospitals For Severely Ill Patients (Marijuana Moment)

• Kansas City, MO: City Council Approves Measure Eliminating Pre-Employment Marijuana Testing for Most City Workers (NORML)

• Hundreds prescribed medical cannabis in bid to persuade lawmakers to offer it on NHS (Mirror)

• Mississippi Lawmakers Move to Implement Medical Cannabis Legislation (High Times)

• Los Angeles: District Attorney to Vacate Some 60,000 Marijuana Convictions (NORML)

• DEA Still Insists Marijuana Has No 'Accepted Medical Use' (Reason)

• The Making Of New York’s $150 Million ‘Cannabis Campus’ (Forbes)

• What are they smoking? CNN says study found cannabis could double heart attack risk – but did it? (The Cannigma)

• Pennsylvania Lawmakers Unveil Marijuana Legalization Bill With Focus On Social Equity (Marijuana Moment)

• Your Smartphone Can Tell If You’re High On Marijuana, Study Finds (Forbes)

• Nebraska Advocates Launch Signature Drive For 2022 Medical Marijuana Ballot Measures (Marijuana Moment)

• Curbside Recreational Weed Pickups End in Massachusetts (High Times)

• Federal Grant Approved to Study Medical Marijuana Impact in Arkansas (High Times)

LSD

• Cannot treat LSD and its carrier material as separate, says court Cannot treat LSD and its carrier material as separate, says court (The Times of India)

Magic Mushrooms

• From Sugar To Psychedelics: The European Companies Testing Biosynthetic Psilocybin In Humans (Forbes)

• Decrim California’s Plan to Regulate Psilocybin Via Ballot (Truffle Report)

• My Bipolar Mother's Quest For Relief With Magic Mushrooms (VICE)

• Oregon Board to Vote on Psilocybin Facilitator Program (Truffle Report)

• Red Light Holland: Initial Results From Red Light Oregon Market Research in Oregon Show 86% of Adults Interested in Psilocybin Services are Interested in Microdosing (Psilocybin Alpha)

MDMA

• MINDCURE Launches “Desire Project” To Treat Female Hypoactive Sexual Desire Disorder With MDMA-Assisted Psychotherapy (Psilocybin Alpha)

• Levels of MDMA and cocaine in river running through Glastonbury Festival site so high they could harm wildlife, scientists say (Independent.ie)

• Police urging parents to inspect Halloween candy after ecstasy discovered (Fox News)

• MDMA: A Catalyst for ED-PTSD Treatment (Psychedelic Science Review)

DMT

• Companies Compete to Create DMT Therapies (Lucid News)

Ayahuasca

• Will Smith Embarked On A Dozen Ayahuasca Rituals In Peru After Denzel Washington Sold Him On The “F*ck It 50s” (BroBible)

• Man charged after alleged sex assault linked to ayahuasca ceremony (CBC)

Novel Psychoactive Substances

• Delix Therapeutics Closes $70 Million Series A Financing to Advance Pipeline of Novel Psychoplastogen Therapeutics to Treat Brain Disorders (Psilocybin Alpha)

• BetterLife Files Patent for TD-0148A for Treatment of Cluster Headaches and Related Disorders (Psilocybin Alpha)

• Mindset Pharma Expands Pipeline: Identifies Additional Next Generation 5-MeO-DMT-Inspired Lead Candidates (Psilocybin Alpha)

Ketamine

• Ketamine use on patients with excited delirium and cocaine intoxication increases intubation rate (News-Medical.net)

Miscellaneous

• Ending The Silence Around Psychedelic Therapy Abuse (Mad in America)

• Can Psychedelic Drugs Treat Physical Pain? (Scientific American)

• Toronto University Health Network Launches Psychedelic Psychotherapy Research Centre (Psilocybin Alpha)

• Seattle City Council Takes First Step Toward Decriminalizing Psychedelic Plants And Fungi (Marijuana Moment)

• Florida Lawmakers Introduce Bill to Study Psychedelics (Truffle Report)

• DoubleBlind Magazine's First-Ever Psychedelics Billboard Campaign Is Turning New Yorkers On To Plant Medicine (Benzinga)

• Psychedelics might reduce internalized shame and complex trauma symptoms in those with a history of childhood abuse (PsyPost)

• Massachusetts Lawmakers Discuss Drug Decriminalization And Safe Injection Sites At Hearing (Marijuana Moment)

• Bay Staters for Natural Medicine on Easthampton Decrim (Truffle Report)

• ‘Psychedelics renaissance’: new wave of research puts hallucinogenics forward to treat mental health (The Guardian)

• Are Psychedelic Drugs the Answer to Veterans’ PTSD? (Men's Health)

• 19-Year-Old New Hampshire Lawmaker Prepares Bills To Decriminalize Psilocybin And All Drugs (Marijuana Moment)

• Elon Musk Embraces Potential of Psychedelics at CodeCon (High Times)

• How Effective Is Fireside Project's Psychedelic Hotline? New Study Aims To Find Out (Forbes)

• Psychedelics and Pregnancy: A Look Into the Safety, Research and Legality (Psychedelics Today)

• Pantheistic Insights: Vegetarianism in Psychedelic Culture (The Oak Tree Review)

• 'The End In Mind' Conference Answers Questions About Psychedelics For End-Of-Life Patients (Forbes)

• Community Alert! Arrests and Encounters with Law Enforcement are Increasing (Chacruna)

• People Are Facing Legal Repercussions for Serving Plant Medicine — Here’s What’s Being Done to Help Them (DoubleBlind)

• Does psychedelic microdosing work? Brain study will be the real acid test (The New Daily)

• Psychedelia in the Soviet Union (Reality Sandwich)

• The Mystical Experience Defines Psychedelics (Lucid News)

• Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases (PR Newswire)

• Why Psychedelic Therapy Needs Best Practices & How to Get There (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 9.3.21

Cannabis

• Appeals court rejects lawsuit seeking to force DEA to reschedule marijuana (Marijuana Business Daily)

• Anti-Pot Author Alex Berenson Gets Permanent Twitter Ban (High Times)

• How Much Legal Cannabis Is In California? It’s A State Secret. (Forbes)

• Allowing Public Marijuana Smoking Leads To Bigger NYC Arrest Decline Than In Other Legalized Places (Marijuana Moment)

• Fakkuappu: Japan Struggles with Cannabis Reform (High Times)

• Senators Flooded With Input On Federal Marijuana Legalization Bill (Marijuana Moment)

• Big Pharma Seizes Brazilian Market While Medical Cannabis Bill is Stalled (TalkingDrugs)

• Alabama medical cannabis program might roll out slower than expected (Marijuana Business Daily)

• Swiss Doctors to Prescribe Cannabis Without “Exceptional Authorization” (High Times)

• Legalization Nation: The Dispensary Divide (The Nib)

• New Group Files Another Missouri Marijuana Legalization Initiative For 2022 Ballot (Marijuana Moment)

• Ohio Marijuana Activists Cleared To Collect Signatures For 2022 Legalization Ballot Initiative (Marijuana Moment)

LSD

• How Dock Ellis Made Baseball History on LSD (DoubleBlind)

Magic Mushrooms

• Denver Psychedelics Activists Push To Expand Psilocybin Decriminalization To Allow Gifting And Communal Use (Marijuana Moment)

• Yale researchers discover healing effects of psychedelic drug (Yale Daily News)

• Heroic Hearts Project announces new study with Imperial College London into the physiological and psychological effects of psilocybin on veterans. (Volteface)

• 'Psychedelic renaissance' sees first legal collection of Australia's medicinal magic mushrooms (Australian Broadcasting Corporation)

• The Tragic Story Of Magic Truffles: The Elusive Wild Psilocybe (DoubleBlind)

• Red Light Holland Successfully Completes Canada’s Largest Legal Sale and Import of Psilocybe Truffles into Canada Under a Health Canada Approved Psilocybin Import Permit (Psilocybin Alpha)

DMT

• Microdose Psychedelic Insights Presents the Upcoming DMT Conference, a Deep Dive Into the Dynamic Field of DMT Therapeutics (Benzinga)

Ayahuasca

• A single dose of ayahuasca improves self-perception of speech performance in socially anxious people, study finds (PsyPost)

• Wilma Mahua Campos, Shipibo Ayahuasquera (Chacruna)

• The Importance of Traditional Ayahuasca Techniques with Carlos Tanner (EntheoNation)

5-MeO-DMT

• Psychedelic Toads Emerge In Arizona During Monsoon Season (iHeartRadio)

San Pedro

• The Effects of Mescaline in the San Pedro Cactus (The Third Wave)

Novel Psychoactive Substances

• Mindset Pharma Announces its Next Generation Novel 5-MeO-DMT Psychedelic Analogs Demonstrate a Significantly Improved Safety Profile in Preclinical Results (Psilocybin Alpha)

Nitrous Oxide

• Nitrous oxide: Patel orders Laughing gas review to decide on potential new law (BBC)

Ketamine

• Cops and Paramedics Involved in Elijah McClain’s Death Charged With Homicide (VICE)

Miscellaneous

• Drug Users Are Suing the Canadian Government Over the War on Drugs (VICE)

• DEA Proposes Massive Increase In Marijuana And Psilocybin Production For Research To Develop FDA-Approved Medicines (Marijuana Moment)

• 'QAnon Shaman' to plead guilty in US Capitol riot case (CNN)

• What Is the ‘Collective Unconscious’ and How Can It Help Us Understand Psychedelic Experiences? (Psychedelics Today)

• Can Psychedelics Promote Social Justice and Change the World? (Chacruna)

• Seattle Should Decriminalize All Drugs, City Task Force On Overdose Crisis Recommends (Marijuana Moment)

• Jon Hopkins Announces New Album Music for Psychedelic Therapy, Shares New Song: Listen (Pitchfork)

• Meet the women who regularly microdose psychedelics (Cosmopolitan)

• Glow Time: PsychLight Brings a Powerful Tool to Psychedelic Research (Psychedelic Science Review)

• New Psychedelic Therapy Clinic Opens in Charleston (Johnson City Press)

• Psychedelics Co. Synthesis Institute Closes $7.25M Series A Funding Through Non-Traditional VC Path (Benzinga)

• Psychedelics—The New Psychiatric Craze (Mad in America)

• Field Trip Health Ltd. Announces Launch Of “Kap Co-Operative” Program, Enabling Independent Psychedelic Therapists To Practice At Its Field Trip Health Centers; Also Launches Training Programs To Educate A New Generation Of Psychedelic Clinicians (Psilocybin Alpha)

• Psychedelics in Recovery: 12-Step Peer Support Program (Truffle Report)

• Legal Psychedelic Retreats – What They Are & Where to Find Them (EntheoNation)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 5.7.21

Cannabis

• Mexican Lawmakers Fail To Legalize Marijuana Ahead Of Supreme Court Deadline (Marijuana Moment)

• Alabama Medical Marijuana Bill Heads To Governor’s Desk Following Legislature’s Approval (Marijuana Moment)

• Louisiana House Votes To Legalize Medical Marijuana Flower And Advances Bill To Prepare For Recreational Legalization (Marijuana Moment)

• Texas House Passes Marijuana Decriminalization Bill, Sending It To Senate (Marijuana Moment)

• Philadelphia: Mayor Signs Law Prohibiting Pre-Employment Drug Screening for Cannabis (NORML)

• Frequent Marijuana Consumers Are Actually More Physically Active Than Non-Users, Study Finds, Smashing Stereotypes (Marijuana Moment)

• Neat idea, Canna Bumps: Thanks for keeping marijuana illegal (Leafly)

• Switzerland Just Got One Step Closer to Federally Legalizing Weed (MERRY JANE)

• Cannabis Offers Immediate Nausea Relief, Study Shows (Forbes)

• French Lawmaker Displays Marijuana Joint In Parliament As New Report Calls For Legalization (Marijuana Moment)

• 58% of Americans Don't Know the Difference Between THC and CBD, Survey Says (MERRY JANE)

• Colorado Governor Signs Bill To Expand Medical Marijuana Access For Students In Schools (Marijuana Moment)

• Kansas: House Lawmakers Approve Medical Marijuana Bill (NORML)

• Minnesota Marijuana Legalization Bill Clears 11th House Committee On Path To The Floor (Marijuana Moment)

• Colorado: Legislature Approves Measure Eliminating Civil Penalties for Possessing Between One and Two Ounces of Cannabis (NORML)

• Kansas Lawmakers Approve Medical Marijuana Legalization Bill In Committee (Marijuana Moment)

• Wilmington, Delaware City Council Votes to Support Cannabis Legalization (NORML)

• Cannabis 'gravest threat' to mental health of young people (The Irish Times)

Magic Mushrooms

• MycoMeditations' Psilocybin-Assisted Wellness Retreat Urgently Addresses COVID-19's Impact on Mental Health (PR Newswire)

• Psychedelics and Veganism: Personal Change Catalysed by Psilocybin (Sam Woolfe)

• Psyched Wellness Signs Supply Agreement for Amanita Muscaria (Psilocybin Alpha)

• Psilocybin and the Will to Live (Psychedelic Science Review)

• Optimi Health Partnership with Numinus Wellness Provides Update on First All-Natural Psilocybin Protocol (Psilocybin Alpha)

MDMA

• A Psychedelic Drug Passes a Big Test for PTSD Treatment (The New York Times)

Mescaline

• A Century of Mescaline (Chacruna)

Synthetic Cannabinoids

• The Power of Synthetic Cannabinoids and Why Big Pharma Prefers Them (Cannabis Science and Technology)

Ketamine

• Champignon Brands Changes Name to Braxia Scientific to Reflect the Integration of Ketamine and Psychedelic Clinics and its Research and Development Priorities (Psilocybin Alpha)

• Ketamine, esketamine effective for depression but have limitations (Healio)

• What’s in the ketamine bill that just passed the House Judiciary Committee in Colorado? (KDVR)

Miscellaneous

• 100 Most Influential People in Psychedelics (Psychedelic Invest)

• Texas House Approves Psychedelics Research Bill As Marijuana Reform Measures Also Advance (Marijuana Moment)

• Can a genetic test predict your response to psychedelic drugs? (New Atlas)

• What Happens When Big Pharma Starts Selling Mass-Market Hallucinogens (The Federalist)

• Now that New York Legalized Cannabis, Could Psychedelics Be Next? (DoubleBlind)

• The push to legalize psychedelics has ignored Indigenous communities (Mic)

• Psychedelics at a Crossroads: We Need Constructive Not Extractive Capital (Dr. Bronner's)

• Red Light Holland Receives Patent Pending Status For ‘Find Your Dose’ Customization of Microdosing Kits Based on Biometric and Movement Data (Psilocybin Alpha)

• Psychedelics are transforming the way we understand depression and its treatment (The Irish Times)

• Portland Advocates Push for Psychedelic Decriminalization (Truffle Report)

• Can Psychedelics Provide Relief for Autistic Individuals? (Psychedelics Today)

• Nova Mentis Launches Autism Clinical Study (Psilocybin Alpha)

• Why drugs should be not only decriminalised, but fully legalised (New Statesman)

• Ketanserin’s Contributions to Psychedelic Research (Psychedelic Science Review)

• MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics (Psilocybin Alpha)

• Navigating the Legal Landscape of Psychedelics (Sam Woolfe)

• Culture, entrepreneurial spirit makes Okanagan viable for psychedelic research (iNFOnews)

• Psychedelics and Ecological Consciousness (Reality Sandwich)

• DoubleBlind Editor-in-Chief Shelby Hartman on Covering the World of Psychedelics (Muse by Clio)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.